Literature DB >> 3392567

MR imaging as predictor of delayed posttraumatic cerebral hemorrhage.

T Tanaka1, T Sakai, K Uemura, A Teramura, I Fujishima, T Yamamoto.   

Abstract

The occurrence of delayed traumatic intracerebral hemorrhage or hematomas was predicted in four patients by T2-weighted magnetic resonance (MR) imaging. From June, 1986, through February, 1987, 42 patients with head injury were admitted to the Neurosurgical Service of the Seirei Mikatabara General Hospital. Cerebral contusion was suspected in six of these patients. Although the initial computerized tomography (CT) scans showed no cerebral parenchymal lesion, the initial symptoms were more serious than might have been expected from the initial CT findings and/or because their initial CT scans showed intracranial extracerebral hemorrhage. In all six, the initial CT scans were obtained within 2 hours after the injury and were followed by MR imaging. In four patients, T2-weighted MR images revealed areas of increased signal intensity in the cerebral parenchyma, where hemorrhagic changes were subsequently demonstrated by follow-up CT scans. In the remaining two, T2-weighted MR images showed no parenchymal lesion and subsequent CT scans confirmed the absence of hemorrhagic change; these two patients were discharged from the hospital without neurological deficits. It is concluded that MR imaging is useful in predicting delayed hemorrhages.

Entities:  

Mesh:

Year:  1988        PMID: 3392567     DOI: 10.3171/jns.1988.69.2.0203

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  2 in total

1.  Criteria for conservative treatment of supratentorial acute subdural haematomas.

Authors:  C W Wong
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Delayed traumatic intracerebral hemorrhage associated with dolichoectasia of the middle cerebral artery.

Authors:  Aito Watanabe; Satoshi Tsutsumi; Hiroki Sugiyama; Senshu Nonaka; Hidehiro Okura; Hisato Ishii
Journal:  Radiol Case Rep       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.